Membrane fusion
Membrane fusion is the process in which two opposing membranes are joined into one contiguous membrane.
In synthetic systems, i.e. liposomes membrane fusion is readily achieved upon adding divalent cations such as Ca2+ to liposomes containing negatively charged lipids.
There are major differences between this sort of membrane fusion and that found in biological systems in that in biological system:
It is therefore not surprising that biological membrane fusion involves the action of proteins to maintain and uphold these stringent requirement.
Membrane fusion events can be classified into 2 categories:
* exoplasmic fusion
* endoplasmic fusion
The difference between endoplasmic and exoplasmic fusion relates to the nature of the interacting bilayer leaflets.
Interestingly the mechanism of fusion seems to be dramatically different between these two processes and requires completely different sets of proteins.
Exoplasmic membrane fusion
Exoplasmic membrane fusion takes place when the interacting leaflets of the bilayer are those facing the extracellular space, or any other space in the cell separated by an even number membranes (such as the ER and Golgi lumen).
Example of such fusion events are several:
The machinery involved in this sort of fusion event seems to be a single spike protein residing on the membrane of one of the opposing membranes .
Proteins such as these have been found on the sperm plasma membrane as well as in the virus envelope. The best characterised of these fusogenic proteins is the influenza trimeric hemagglutinin spike glycoprotein (or HA).
This protein is made up of a single chain that is then cleaved into two chains held together by disulphide bonds. Cleavage results in the ``release'' of the amino-terminus of the b chain, that contains a stretch of hydrophobic amino-acids. This is considered to be the fusion peptide, i.e. the part of the protein that inserts into the target membrane to initiate membrane fusion.
(Note that if the protein were not cleaved, this segment would only be part of the contiguous chain of the proteins and not able to do its job.)
Membrane fusion is initiated by acidification that triggers a conformation change in the proteins.
Fusion of a virus and a cell membrane
Other viruses contain spike glycoproteins that share common features to HA such as cleavage generating a hydrophobic N-terminus of the ``B'' chain.
Most of them are also trimeric such as HA.
Perhaps the most famous example is the GP120 spike glycoprotein from HIV.
Exoplasmic membrane fusion specificity
The specificity in the interaction, that is making sure that the correct membranes fuse is a crucial component of the fusion machinery.
One can imagine that none of us would be sitting here if the sperms would fuse with one another sperm instead of the oocyte.
The same is true with viruses targeting a host membrane.
So how then does specificity arise?
Endoplasmic membrane fusion mechanism & specificity
Endoplasmic membrane fusion occurs in all ``communication'' events between different cellular compartments, such as vesicles that have bud from ER fusing with the Golgi, chromafin granules fusing with the plasma membrane, synaptic vesicles full of neurotransmitters fusing with the plasma membrane, etc.
The mechanism behind these fusion events seems to be dramatically different from exoplasmic fusion and involve a multitude of components utilising ATP.
The mechanism of endoplasmic membrane fusion is not that well understood.
The common theme behind endoplasmic membrane fusion is the SNARE Hypothesis. The SNARE hypothesis delineates between the target membrane and the vesicle membrane that partake in the fusion reaction. The vesicle membrane contains an element that specifies its destination (a V-SNARE), while the target membrane contains elements that designates its identity (a T-SNARE).
Interests in the SNARE hypothesis began at an improbable biological juncture between yeast and neurones. Yeast has long been used as a genetic tool in biological research and has been especially useful in the field of vesicular transport. Many genetic mutations and subsequent proteins have been identified that result in defective and blockage in particular stages in vesicular transport. Considerable research in the last several years have identified numerous proteins that are critical in synaptic vesicle maturation and fusion. Interestingly many of these proteins are homologous to yeast proteins and it was shown that vesicular transport in both these eukaryotic systems is very similar.
Since then many more V-SNAREs and T-SNAREs have been discovered in a variety of tissues, and in fact, it is assumed that most if not all intracellular vesicular transport utilises the SNARE machinery.
Why the irritating names: SNARE.
Well this all has to do with historical reasons.
So how is fusion supposed to take place?
All this sounds very nice however recently ``troublesome'' finding have plagued the SNARE hypothesis.
Perhaps the worst detriment in the rosy world of the SNARE hypothesis is the fact V-SNAREs T-SNAREs may be found in the same membrane
When things go wrong, or not at all in endoplasmic membrane fusion
Some of the most lethal toxins secreted by clostridia bacteria target elements of the SNARE complex directly.
The toxins are usually composed of 2 polypeptides chains:
|
Membrane fission & Endocytosis
Membrane fission events are extremely common events in cellular biology.
Most, if not all vesicles start their ``life'' as a result of a membrane undergoing budding or invagination.
Receptor mediated endocytosis:
This process is responsible for the transport of specific proteins (e.g. growth factors, iron binding proteins, antibodies) into the cell.
Transport involves initial binding of the proteins to transmembrane protein receptors on the outer surface of the plasma membrane followed by invagination of portions of the membrane to form vesicles containing the protein-receptor complex.
Endocytosis begins when proteins bound to receptor accumulate in ``coated pits'' - specialised regions of the membrane where it is indented and coated on its cytoplasmic side with a bristle-like coat composed of two proteins: clathrin and protein adapters.
Rapid internalisation of the receptors requires the tetrapeptide sequence Asn-Pro-X-Tyr which occurs in the first 22 residues of the receptor cytoplasmic domain. Following the assembly of the coated pit, it is then excised or pinched off from the membrane to form a coated vesicle.
Measurements suggest that 2,500 coated vesicles leave the inner surface of the plasma membrane every minute.
Very quickly after coated vesicles leave the plasma membrane, an uncoating ATPase removes the clathrin ``overcoats'' from the vesicle which then fuse with cytoplasmic vesicles termed endosomes.
The internal pH of the endosome is maintained between pH 5 & 6 by ATP-driven proton pumps.
The effect of this low pH within the endosome is generally to cause dissociation of the ligand from the receptor.
Often but not always, the ligand passes to another cytoplasmic vesicle, the lysosome to be degraded by proteases.
The receptor recycles back to the cell surface to bind another ligand molecule.
The whole cycle may take only 10 minutes.
Viral uptake
Some viruses make use of most of the cellular machinery in order to infect the cell and destroy it.
Influenza A is a member of the orthomyxoviruses, which are enveloped viruses containing RNA as their genetic material. Influenza is responsible for some of the most devastating plagues in world history such as the pandemics of 1743, 1889-1890 and 1918-1919, the later resulting in the death of approximately 40-100 million people.
One of the things that puzzled scientists for some time was that fact that pH of vesicles along the Golgi secretory pathway is acidic enough to cause the conformation induced fusion of the hemagglutinin protein. Why then does fusion not take place when the HA is exported to the plasma membrane?
It does not because the virus makes a small ion channel (that does not get included in the final virion for obvious reasons) that uncouples the resident H+ pump, thereby allowing the protein to remain in its pre-fusion capable form.